A chlorin-lipid nanovesicle nucleus drug for amplified therapeutic effects of lung cancer by internal radiotherapy combined with the Cerenkov radiation-induced photodynamic therapy

¹³¹I-BSA loaded chlorin-lipid nanovesicle constructed from Ce6 and LPPC conjugates for synergistic therapeutic effects of lung cancer by radiotherapy of ¹³¹I combined with Cerenkov Radiation (CR)-induced photodynamic therapy.